Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2025-02-28 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于完成工商变更登记并换发营业执照的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the completion of business registration changes and the issuance of a new business license for the company 盈康生命科技股份有限公司. It references prior announcements about changes in registered capital and share repurchases but does not contain financial statements or detailed financial data. The document is short (951 characters) and serves as a formal notification of administrative updates rather than a financial report or detailed management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-28 Chinese
关于公司与专业投资机构共同投资的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a joint investment between the company and professional investment institutions, including details about the establishment and registration of an investment fund. It includes information about the fund's registration, capital commitments, and regulatory filings related to the fund. The document does not contain financial statements, earnings data, or detailed management analysis. It is a regulatory announcement about investment activity and compliance with disclosure obligations. The document length is short (1088 characters) and it is clearly an announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2025-02-17 Chinese
第六届董事会第十五次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's 15th interim meeting of the 6th Board of Directors. It includes details about the meeting's convening, attendance, and voting results on a specific action plan. There is no financial data, no detailed report, and no mention of an annual or quarterly report. The content focuses on board decisions and governance matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2025-01-15 Chinese
关于“质量回报双提升”行动方案的公告
Capital/Financing Update Classification · 90% confidence The document is a detailed announcement from 盈康生命科技股份有限公司 about their "quality and return improvement" action plan. It includes extensive information on company strategy, financial performance for 2023, governance, ESG initiatives, shareholder activities including share issuance, share repurchases, and stock incentive plans. The document is not a full annual or quarterly report but rather a comprehensive corporate update focusing on strategic initiatives, shareholder returns, and governance. It also references regulatory approvals and shareholder activities but does not present full financial statements or detailed financial analysis typical of an Annual Report (10-K) or Interim Report (IR). The document length is under 5,000 characters, but it contains substantive content rather than just an announcement of a report. It is not a certification or a simple announcement. The content aligns best with a Capital/Financing Update (CAP) because it discusses share issuance, share repurchases, and shareholder return mechanisms in detail, alongside strategic and operational updates. Therefore, the most appropriate classification is CAP with high confidence.
2025-01-15 Chinese
关于部分回购股份注销完成暨股份变动的公告
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from 盈康生命科技股份有限公司 regarding the completion of cancellation of repurchased shares and the resulting change in share capital. It details the number of shares cancelled, the dates of board and shareholder meetings approving the cancellation, and the impact on the company's total share capital. The document does not contain financial statements or detailed financial analysis but is a formal disclosure of a share repurchase and cancellation event. This fits the category of a Transaction in Own Shares (POS), which covers announcements of company buybacks or share cancellations.
2024-12-26 Chinese
2024年第四次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2024 fourth extraordinary general meeting of shareholders of 盈康生命科技股份有限公司. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. The document does not contain financial statements or detailed financial analysis but focuses on the voting outcomes and procedural compliance. The length is about 2400 characters, which is relatively short and typical for a voting results announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-12-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.